Related Experiment Video
Updated: Jun 7, 2026
11:18
Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
Published on: September 12, 2014
Novel antidepressants and panic disorder: evidence beyond current guidelines
Alessandro Serretti1, Alberto Chiesa, Raffaella Calati
1Institute of Psychiatry, University of Bologna, Bologna, Italy. alessandro.serretti@unibo.it
Neuropsychobiology
|October 22, 2010
Summary
Novel antidepressants like mirtazapine, reboxetine, milnacipran, and duloxetine show preliminary promise for panic disorder treatment. However, current evidence is limited, necessitating further high-quality research to confirm efficacy and safety.
Area of Science:
- Pharmacology
- Psychiatry
- Clinical Trials
Background:
- Panic disorder is a debilitating condition.
- Effective pharmacological treatments are crucial for managing panic disorder.
- Novel antidepressants are being explored as potential therapeutic options.
Purpose of the Study:
- To review existing evidence on the efficacy and side effects of new antidepressants for panic disorder.
- To assess the quality of studies evaluating these novel agents.
Main Methods:
- Comprehensive literature search of MEDLINE, ISI Web of Knowledge, and reference lists.
- Inclusion of controlled and uncontrolled trials published up to September 2009.
- Systematic assessment of the quality of included studies.
Main Results:
- Fourteen studies, mostly of poor quality, were analyzed.
- Mirtazapine demonstrated potential efficacy in uncontrolled studies, comparable to SSRIs.
- Reboxetine showed efficacy over placebo but was less effective than SSRIs.
- Preliminary evidence suggested milnacipran and duloxetine may also be beneficial.
- Most investigated drugs were generally well-tolerated.
Conclusions:
- Convincing evidence for the efficacy of mirtazapine, reboxetine, milnacipran, and duloxetine in panic disorder is currently lacking.
- Positive preliminary findings warrant further rigorous investigation.
- High-quality research is needed to establish the role of these novel antidepressants.
Related Concept Videos
01:27Panic Disorder
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.